Kirov MY et al., 2001-10: A randomised controlled pilot trial of intravenous methylene blue in septic shock, showing the dose range actually used in a published human trial: a 2 mg/kg bolus then a stepped infusion up to 2 mg/kg/hr.
MB was administered as an intravenous bolus injection (2 mg/kg), followed 2 hrs later by infusion at stepwise increasing rates of 0.25, 0.5, 1, and 2 mg/kg/hr that were maintained for 1 hr each.
Kirov MY et al., 2001-10: A randomised controlled pilot trial of intravenous methylene blue in septic shock, showing the dose range actually used in a published human trial: a 2 mg/kg bolus then a stepped infusion up to 2 mg/kg/hr. Study type: prospective, randomised, controlled, open-label pilot trial. N=20 (10 MB, 10 saline). Country: Russia (Northern State Medical University, Arkhangelsk). Dose: 2 mg/kg IV bolus then 0.25-2 mg/kg/hr infusion. Comparator: isotonic saline plus conventional treatment. Funder/conflicts: not stated in the abstract; check full text. Outcome: MAP rose and catecholamine requirements fell; the trial was not powered for mortality. Also filed as MTI-43, MTC-113 (claims C3, C5, F5). Study type: randomized trial.
